CPP
MRK icon

Crow Point Partners’s Merck MRK Stock Holding History

Crow Point Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,746
Closed -$106K – 261
2017
Q1 		$106K Buy
1,746
+261
+18% +$15.8K 0.02% 180
2016
Q4 		$83K Sell
1,485
-3,811
-72% -$223K 0.01% 170
2016
Q3 		$313K Buy
+5,296
New +$310K 0.05% 102
2015
Q3 		$352K Buy
7,462
+6,948
+1,352% +$369K 0.05% 142
2015
Q2 		$28K Buy
514
+346
+206% +$19.4K ﹤0.01% 243
2015
Q1 		$10K Buy
+168
New +$9.51K ﹤0.01% 235

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Crow Point Partners's MRK Position: Q2 2017 in Review

Crow Point Partners sold out of Merck (MRK) in Q2 2017, closing a stake of 1,746 shares — an estimated $106K sold.

Crow Point Partners first reported a position in MRK in Q1 2015 and held it in 6 quarters. The position peaked at $352K in Q3 2015. 1,926 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Crow Point Partners reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
  • Crow Point Partners sold 1,746 Merck shares in Q2 2017, an estimated $106K.
  • Crow Point Partners first reported a position in Merck in Q1 2015 and held it in 6 quarters.
  • Crow Point Partners's Merck position peaked at $352K in Q3 2015.
  • 1,926 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Crow Point Partners's 13F filing for Q2 2017, filed 17 Jul 2017.